Professional Associations

This page includes news coverage of medical associations and medical societies. Use these links to find focused news coverage from specific organizations: Cardiology Associations, Healthcare Associations, Radiology Associations.

Thumbnail

Edwards gains CE mark for first transcatheter tricuspid treatment

Edwards Lifesciences has received CE mark approval for its Cardioband Tricuspid Valve Reconstruction System, making it the first commercially available transcatheter therapy to treat tricuspid valve heart disease.

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

DUBLIN — April 9, 2018 — Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval to begin an investigational device exemption (IDE) pivotal trial to evaluate the Symplicity Spyral(TM) renal denervation system in patients with high blood pressure (hypertension).

Study Shows Positive Results with Medtronic Cryoballoon for Patients with Persistent Atrial Fibrillation

DUBLIN and BARCELONA, Spain - MARCH 19, 2018 - Medtronic plc (NYSE: MDT) today announced one-year results from the CRYO4PERSISTENT AF study of ablation with the Arctic Front Advance(TM) Cryoballoon to isolate the pulmonary veins in patients with symptomatic persistent atrial fibrillation (AF).

New $1 million research initiative supports early career vascular disease investigator research

The American Heart Association and VIVA Physicians, Inc. announced today a two-year $1 million grant program to support research initiatives in vascular disease and career development opportunities for early career investigators at the post-doctoral level.

auditorium conference

TCT paradox: Patients more likely to survive MI during interventional cardiology conference

Patients hospitalized with acute myocardial infarction (AMI) actually fare better when some of the top minds in interventional cardiology are away at the annual Transcatheter Cardiovascular Therapeutics (TCT) meeting, suggests a study published March 9 in the Journal of the American Heart Association.

Thumbnail

Non-hospital-based facilities offering cardiac imaging services a rarity in Massachusetts

In 2017, Anthem implemented a new policy that requires outpatient MR and CT scans not considered medically necessary to be completed at a freestanding imaging facility to receive coverage. This went into effect in several states, sparking its fair share of controversy along the way, and a team of Boston-based researchers wanted to know how such a policy could impact patient care in Massachusetts.

HeartFlow Enters into Licensing Agreement with Cedars-Sinai for Coronary Plaque Assessment Technology

REDWOOD CITY, Calif., March 1, 2018 — HeartFlow, Inc. today announced that it has entered into a licensing and technology transfer agreement with Cedars-Sinai in Los Angeles for AutoPlaque technology, a software tool used to detect and characterize coronary artery plaque based on coronary computed tomography angiography (CCTA) images.

Thumbnail

After ORBITA: Looking at Angina Through a New Lens

Could the ORBITA trial’s enduring value be in prompting the cardiology community to rethink how it diagnoses, treats and even defines angina?

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.